课题基金 / 基金详情

REVERSING EPITHELIAL TO MESENCHYMAL TRANSITION BY TARGETED EPIGENETIC EDITING IN BREAST CANCER

REVERSING EPITHELIAL TO MESENCHYMAL TRANSITION BY TARGETED EPIGENETIC EDITING IN BREAST CANCER
通过靶向表观遗传编辑在乳腺癌中逆转上皮细胞向间质细胞的转变
批准号:
nhmrc : 1147528
负责人:
A/Pr Andrew Redfern
金额:
$90.17万
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2018
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2018-01-01 至 2022-12-31

项目摘要

项目成果

A/Pr Andrew Redfern的其他基金

相似基金

相关文献

中文摘要
翻译
癌细胞在身体周围的扩散涉及细胞的变化,这些细胞允许它们迁移到血管,旅行然后侵入其他器官,这一过程被称为上皮间充质转化(EMT)。EMT还使细胞对我们最好的治疗方法不那么敏感。EMT包括开启激活这些变化的基因,关闭沉默这些变化的基因。我们将开发能够逆转这一过程的疗法,既减少癌症扩散,又使癌症治疗更有效。
英文摘要
Cancer cell spread around the body involves changes in the cells which allow them to migrate into blood vessels, travel and then invade other organs, a process called epithelial mesenchymal transition (EMT). EMT also makes cells less sensitive to our best treatments. EMT involves switching on genes that activate these changes and switching off genes that silence them. We will develop therapy that will reverse this process, both reducing cancer spread and making cancer treatment more effective.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
REVERSING EPITHELIAL TO MESENCHYMAL TRANSITION BY TARGETED EPIGENETIC EDITING IN BREAST CANCER
  • 批准号:
    nhmrc : GNT1147528
  • 项目类别:
    Project Grants
  • 资助金额:
    $133.37万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Andrew Redfern
  • 依托单位:
Activation of BMP4 signalling to inhibit breast cancer metastasis
  • 批准号:
    nhmrc : GNT1121199
  • 项目类别:
    Project Grants
  • 资助金额:
    $74.87万
  • 财政年份:
    2017
  • 负责人:
    A/Pr Andrew Redfern
  • 依托单位:
Activation of BMP4 signalling to inhibit breast cancer metastasis
  • 批准号:
    nhmrc : 1121199
  • 项目类别:
    Project Grants
  • 资助金额:
    $51.15万
  • 财政年份:
    2017
  • 负责人:
    A/Pr Andrew Redfern
  • 依托单位:
CHARACTERIZATION OF A NEW SUBTYPE OF AGGRESSIVE BREAST CANCER
  • 批准号:
    nhmrc : GNT1130212
  • 项目类别:
    Project Grants
  • 资助金额:
    $76.32万
  • 财政年份:
    2017
  • 负责人:
    A/Pr Andrew Redfern
  • 依托单位:
海外基金